DÜSSELDORF, Germany, April 20, 2023 /PRNewswire/ — A new survey of 300 endoscopists has revealed that nearly 70 percent of endoscopists agreed that correctly measuring polyps is crucial to achieving an accurate diagnosis .
This survey found that most endoscopists currently find it difficult to measure polyps accurately, with nearly three-quarters saying a more accurate tool is needed to measure polyps.
To assist endoscopists, FUJIFILM Europe has launched SCALE EYE, a virtual scaling solution designed to help endoscopists estimate the size of lesions in the colon. Integrated into FUJIFILM’s ELUXEO Ultra platform, SCALE EYE enables endoscopists to measure polyps with greater precision and, as a result, help clinicians determine necessary treatment at the flip of a switch.
Although 90 percent of endoscopists agree on the importance of polyp measurement, most use visual estimation, open biopsy forceps, or endoscopic rulers, rather than innovative solutions.
Colorectal cancer is the second most common cancer in Europe, accounting for 12.7% of all new cancer diagnoses in 2020.[1] Early detection and diagnosis of cancer and precancerous lesions have been shown to significantly improve patient outcomes.[2]
Prof. Cesare Hassan, Associate Professor of Gastroenterology, Humanitas University, Italy, said: “SCALE EYE is a disruptive technology from Fujifilm. It’s not an evolution, it’s a revolution. This is disruptive because before this, we couldn’t measure the lesion in the colon with the same precision. This is also of great clinical interest because the size of the polyp tells us if this patient needs potential post-polypectomy surveillance.”
According to the survey, 88 percent of endoscopists found polyp characterization, which is also made possible by Fujifilm’s CAD-EYE technology, crucial to achieving an accurate diagnosis.
Saskia Papa, Senior Product Manager at FUJIFILM Europe GmbH said:
“Our new research clearly illustrates that SCALE EYE is another technological leap in the fight against colorectal cancer. The results of this study echo what we have been hearing, across our markets, about the potentially transformative role of this scaling solution. to ensure accurate detection and characterization of lesions With SCALE EYE, we have a real opportunity to further help clinicians improve the quality of colonoscopy, from detection to treatment, and ultimately to improve patients’ lives. We look forward to sharing this technology with attendees at ESGE 2023 in Dublin.”
NOTES TO EDITORS
For more information, contact nina.strupeit@fujifilm.com
About Fujifilm in Europe
Fujifilm operates more than 50 group companies and branches in Europe and employs more than 6,000 people in RD, manufacturing, sales and service, with FUJIFILM Europe GmbH, located in Ratingen, Germany, serving as the strategic headquarters for the region. Throughout Europe, Fujifilm entities serve a variety of industries including medical technology, biopharmaceuticals, electronic materials, industrial products, chemicals, graphics systems, optical devices, data storage and all aspects of photography. Over the past 20 years, the company has focused more intensely on healthcare, from diagnosis to prevention and treatment. Today, Fujifilm in Europe offers the full spectrum of patient care, as well as research, development and manufacturing of advanced therapies, gene therapies and vaccines, as well as providing cell culture media and regenerative medicine solutions.
For more information, visit: fujifilm.com
About SCALE EYE
How does it work
The SCALE EYE system includes the newly developed endoscope EC-760S-A/M, L, which is equipped with a class 1 laser. The laser spot is visible within the endoscopic image. The position of the laser spot changes in relation to the distance between the endoscope tip and the object. Depending on the position of this laser point, the size of the scale interval is automatically adjusted.
User interface
The scale size ranges from 5mm to 10mm to 20mm, and turning the function on and off can be operated simply by the switch on the endoscope. The virtual scale is displayed on the same endoscopic monitor in real time and does not require a separate monitor. The software for SCALE EYE (EW10-VM01) can be installed on the EX-1 expansion unit, which can also be used to use CAD EYE[3] setection and characterization.
About ELUXEO Ultra
Fujifilm’s Eluxeo Ultra system is one of the first endoscopy platforms to detect and characterize lesions in real time. Enhances Fujifilm’s existing ELUXEO system by incorporating SCALE EYE, a real-time virtual scaling feature designed to help endoscopists estimate the size of colonic lesions, and ColoAssist PRO, our real-time endoscope visualization system to offer a complete package for endoscopists. These are the latest additions to the ELUXEO Ultra family of endoscopy technologies, following the launch of CAD EYE, a colon polyp detection and characterization feature using AI technology. The ELUXEO Ultra platform will adapt to a range of future tools and technologies as they evolve, so Fujifilm’s best endoscopy system for today’s patients will remain tomorrow’s.
[1] Burden of colorectal cancer in the EU-27, European Commission. 2021. https://ecis.jrc.ec.europa.eu/pdf/Colorectal_cancer_factsheet-Mar_2021.pdf
[2] World Cancer Day 2019: Emphasis on early detection. 2019. https://ascopost.com/News/59711
[3] CAD EYE is a Fujifilm branded feature to aid computer-aided diagnosis (CAD) in endoscopy. The feature was designed using Deep Learning, which is a form of artificial intelligence technology and does not automatically change the performance or accuracy of the system once installed. CAD EYE can be used by installing “Endoscopy Support Program EW10-EC02” in the EX-1 expansion unit.
Logo – https://mma.prnewswire.com/media/1496681…
View original content: https://www.prnewswire.com/es/comunicados-de-prensa/fujifilm-europeretos-a-los-que-se-enfrentan-los-endoscopistas-en-la-medicion-de-polipos-301803365.html
